Glycans in Vaccine Development

Glycans are at the center of many disorders and diseases sparking the possibility of exploiting them for therapeutic and diagnostic purposes. There are many biochemical pathways and diseases in which glycans are intricately involved. Gaging the vast potential and the promise that glycobiology holds, many pharma and biotech companies have already started allocating their R&D budget to it. Presently, with our drug arsenal fast depleting against drug resistant and mutant pathogens, glycobiology hold an untapped source of new candidate drugs.

  • Glycoconjugate vaccines
  • Glycoengineering of immunogens
  • Biomarkers in drug design
  • Screening and drug design
  • Drug interaction in cellular networking
  • Biodefense vaccine mechanism

Related Conference of Glycans in Vaccine Development

September 08-09, 2025

23rd International Conference on Structural Biology

Frankfurt, Germany
September 29-30, 2025

21st World Congress on Structural Biology

Aix-en-Provence, France
May 04-05, 2026

7th International Conference on Drug Chemistry

Paris, France

Glycans in Vaccine Development Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in